Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Benjamin Steinberg

Concepts (410)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
128
2026
558
30.160
 Why?
Anticoagulants
50
2026
748
8.500
 Why?
Anti-Arrhythmia Agents
24
2026
144
6.290
 Why?
Stroke
36
2025
1271
5.770
 Why?
Catheter Ablation
25
2025
355
5.560
 Why?
Registries
37
2025
2410
3.820
 Why?
Heart Failure
28
2025
2326
3.700
 Why?
Patient Reported Outcome Measures
16
2024
498
3.670
 Why?
Warfarin
15
2023
179
3.220
 Why?
Heart Rate
15
2026
856
2.660
 Why?
Electrocardiography, Ambulatory
4
2024
63
2.620
 Why?
Sotalol
8
2025
13
2.460
 Why?
Hemorrhage
22
2026
822
2.440
 Why?
Defibrillators, Implantable
12
2025
387
2.360
 Why?
Thromboembolism
8
2019
129
2.330
 Why?
Aged
101
2026
26215
2.160
 Why?
Electric Countershock
8
2022
126
1.990
 Why?
Treatment Outcome
61
2026
11793
1.890
 Why?
Risk Assessment
29
2026
3752
1.890
 Why?
Cardiac Resynchronization Therapy
5
2022
63
1.680
 Why?
Stroke Volume
13
2025
655
1.650
 Why?
Amiodarone
5
2025
31
1.640
 Why?
Humans
173
2026
145763
1.590
 Why?
Administration, Oral
21
2026
867
1.590
 Why?
Coronary Artery Disease
10
2023
750
1.450
 Why?
Risk Factors
46
2026
10917
1.440
 Why?
Male
114
2026
73003
1.420
 Why?
Wearable Electronic Devices
3
2023
69
1.400
 Why?
Female
115
2026
79035
1.390
 Why?
Pacemaker, Artificial
5
2024
128
1.350
 Why?
Electrocardiography
10
2024
668
1.330
 Why?
Atrial Flutter
4
2026
47
1.290
 Why?
Middle Aged
73
2026
36302
1.280
 Why?
Aged, 80 and over
40
2026
8346
1.170
 Why?
Electrophysiologic Techniques, Cardiac
6
2024
82
1.170
 Why?
Quality of Life
14
2024
3210
1.150
 Why?
Atrial Appendage
3
2025
36
1.110
 Why?
Time Factors
25
2026
7133
1.040
 Why?
Arrhythmias, Cardiac
6
2024
356
1.020
 Why?
Disease Management
4
2020
653
1.020
 Why?
Practice Patterns, Physicians'
4
2025
1372
1.010
 Why?
Cardiac Electrophysiology
3
2024
22
0.990
 Why?
beta-Alanine
4
2014
25
0.990
 Why?
United States
36
2026
16123
0.990
 Why?
Vitamin K
5
2017
46
0.960
 Why?
Follow-Up Studies
20
2025
5428
0.940
 Why?
Prospective Studies
26
2025
8075
0.930
 Why?
Benzimidazoles
4
2014
189
0.900
 Why?
Comorbidity
13
2024
1662
0.890
 Why?
Utah
8
2026
80
0.890
 Why?
Bundle-Branch Block
2
2023
37
0.880
 Why?
Electric Power Supplies
1
2025
47
0.870
 Why?
Heart Atria
6
2024
141
0.830
 Why?
Cardiac Resynchronization Therapy Devices
3
2021
18
0.820
 Why?
Tricuspid Valve
1
2024
43
0.810
 Why?
Retrospective Studies
34
2026
17325
0.800
 Why?
Bundle of His
1
2023
19
0.790
 Why?
Heart Valve Prosthesis
2
2024
129
0.770
 Why?
Lithotripsy
1
2023
49
0.760
 Why?
Pyroptosis
1
2022
5
0.760
 Why?
Tachycardia, Paroxysmal
1
2022
8
0.740
 Why?
Survival Rate
11
2021
2094
0.710
 Why?
Coronary Artery Bypass
4
2013
268
0.700
 Why?
Rivaroxaban
4
2017
271
0.690
 Why?
Glycine
1
2022
186
0.690
 Why?
Cardiac Pacing, Artificial
5
2024
84
0.690
 Why?
Embolism
3
2021
48
0.680
 Why?
Heart Conduction System
3
2023
96
0.670
 Why?
Factor Xa Inhibitors
6
2020
194
0.660
 Why?
Scholarly Communication
1
2020
4
0.650
 Why?
Hospitalization
10
2025
2460
0.650
 Why?
Patient Discharge
3
2024
995
0.650
 Why?
Peer Influence
1
2020
14
0.640
 Why?
Clinical Trials as Topic
3
2024
1062
0.610
 Why?
Decision Support Techniques
4
2025
480
0.600
 Why?
Incidence
12
2025
2933
0.600
 Why?
Self-Assessment
1
2020
74
0.600
 Why?
Thiophenes
3
2014
117
0.590
 Why?
Morpholines
3
2014
130
0.590
 Why?
Workload
1
2020
169
0.560
 Why?
Myocardial Infarction
5
2019
1211
0.560
 Why?
Death, Sudden, Cardiac
2
2017
237
0.550
 Why?
Checklist
1
2019
110
0.540
 Why?
Pyridones
2
2017
209
0.530
 Why?
Dabigatran
5
2017
30
0.530
 Why?
Social Media
1
2020
167
0.520
 Why?
Length of Stay
4
2024
1350
0.510
 Why?
Biomedical Research
2
2021
719
0.510
 Why?
Health Status
2
2020
835
0.500
 Why?
Brain Ischemia
2
2018
359
0.500
 Why?
Heart Failure, Systolic
1
2017
26
0.490
 Why?
Off-Label Use
1
2016
51
0.480
 Why?
Blood Component Transfusion
1
2017
102
0.470
 Why?
Nervous System
1
2016
69
0.460
 Why?
Pyrazoles
2
2017
517
0.460
 Why?
Heparin, Low-Molecular-Weight
1
2015
37
0.450
 Why?
Infusions, Intravenous
3
2026
428
0.440
 Why?
Therapy, Computer-Assisted
1
2015
63
0.440
 Why?
Eligibility Determination
1
2015
72
0.440
 Why?
Medicare
7
2022
904
0.430
 Why?
American Heart Association
2
2017
358
0.430
 Why?
Ventricular Function, Left
2
2022
544
0.420
 Why?
Cardiac Imaging Techniques
1
2014
24
0.420
 Why?
Dementia
3
2025
328
0.420
 Why?
Critical Pathways
2
2013
109
0.410
 Why?
Practice Guidelines as Topic
6
2024
1582
0.410
 Why?
Cardiovascular Diseases
7
2024
2191
0.400
 Why?
Elective Surgical Procedures
1
2015
203
0.400
 Why?
Cardiomyopathies
1
2017
335
0.400
 Why?
Electronic Health Records
5
2024
1202
0.390
 Why?
Intracranial Hemorrhages
1
2014
106
0.390
 Why?
Blood Coagulation
1
2015
274
0.390
 Why?
Drug Administration Schedule
6
2020
782
0.390
 Why?
Guideline Adherence
3
2019
587
0.390
 Why?
Platelet Aggregation Inhibitors
4
2024
499
0.390
 Why?
Gastrointestinal Hemorrhage
1
2014
138
0.380
 Why?
Cerebral Hemorrhage
1
2014
125
0.380
 Why?
Predictive Value of Tests
8
2024
2123
0.370
 Why?
Dose-Response Relationship, Drug
5
2024
2028
0.370
 Why?
Antithrombins
4
2017
71
0.370
 Why?
Drug Dosage Calculations
3
2018
27
0.360
 Why?
Prognosis
10
2025
4329
0.360
 Why?
Angioplasty, Balloon, Coronary
3
2007
156
0.350
 Why?
Natural Language Processing
4
2023
106
0.350
 Why?
Hospitals, University
1
2012
176
0.350
 Why?
Critical Care
3
2016
702
0.350
 Why?
Proportional Hazards Models
6
2021
1330
0.340
 Why?
Prevalence
8
2025
2874
0.340
 Why?
Randomized Controlled Trials as Topic
8
2024
1751
0.340
 Why?
Action Potentials
6
2025
502
0.330
 Why?
Patient Selection
1
2015
739
0.330
 Why?
Heart Valve Prosthesis Implantation
2
2013
198
0.330
 Why?
Global Health
3
2019
403
0.320
 Why?
Hemodynamics
2
2026
1118
0.320
 Why?
Multivariate Analysis
6
2021
1547
0.320
 Why?
Valine
2
2021
83
0.320
 Why?
Echocardiography, Transesophageal
3
2017
132
0.320
 Why?
Age Factors
8
2025
3346
0.310
 Why?
Brain
1
2022
2969
0.310
 Why?
Aspirin
1
2013
406
0.310
 Why?
Triage
1
2012
250
0.300
 Why?
Aortic Valve Stenosis
1
2012
256
0.300
 Why?
Outpatients
3
2020
447
0.290
 Why?
Cause of Death
5
2024
471
0.290
 Why?
Heart Diseases
1
2012
341
0.290
 Why?
Fibrinolytic Agents
2
2013
297
0.290
 Why?
Hemostasis
2
2022
98
0.290
 Why?
Recovery of Function
3
2024
716
0.280
 Why?
Patient Readmission
1
2014
772
0.270
 Why?
Periodicals as Topic
2
2021
209
0.270
 Why?
Atrial Function, Left
2
2024
9
0.270
 Why?
Cost-Benefit Analysis
2
2024
644
0.270
 Why?
Body Mass Index
2
2025
2447
0.260
 Why?
Clinical Decision-Making
2
2021
364
0.260
 Why?
Diagnosis, Computer-Assisted
2
2020
92
0.260
 Why?
Physicians
1
2016
956
0.260
 Why?
Multicenter Studies as Topic
5
2024
413
0.260
 Why?
Logistic Models
5
2021
2139
0.260
 Why?
Myocardial Reperfusion
1
2007
56
0.260
 Why?
Cognition
3
2025
1271
0.250
 Why?
Administration, Intravenous
2
2025
172
0.240
 Why?
Enoxaparin
1
2007
68
0.240
 Why?
Sensitivity and Specificity
4
2020
2000
0.240
 Why?
Propanolamines
2
2017
40
0.240
 Why?
Voltage-Gated Sodium Channel Blockers
1
2026
7
0.240
 Why?
Adult
13
2025
40872
0.230
 Why?
Lidocaine
1
2026
55
0.230
 Why?
Patient Participation
4
2025
446
0.230
 Why?
Severity of Illness Index
4
2024
2933
0.230
 Why?
Cardiovascular Agents
1
2007
166
0.220
 Why?
Sleep Apnea, Obstructive
2
2020
303
0.220
 Why?
Equipment Failure
1
2025
115
0.210
 Why?
Inflammation
1
2016
2883
0.210
 Why?
Hospital Mortality
4
2026
1038
0.210
 Why?
Perioperative Care
3
2016
231
0.210
 Why?
Disease Progression
5
2022
2865
0.200
 Why?
Tachycardia, Supraventricular
1
2024
49
0.200
 Why?
Fee-for-Service Plans
2
2014
99
0.200
 Why?
Ambulatory Surgical Procedures
1
2024
79
0.200
 Why?
Cluster Analysis
2
2022
501
0.200
 Why?
Chi-Square Distribution
2
2015
528
0.200
 Why?
Cohort Studies
8
2021
6032
0.190
 Why?
Hospital Costs
1
2024
125
0.190
 Why?
Equipment Design
1
2025
525
0.190
 Why?
Quality Improvement
1
2012
1296
0.190
 Why?
Postoperative Complications
4
2025
2977
0.190
 Why?
Observational Studies as Topic
2
2014
134
0.190
 Why?
Physicians, Women
1
2024
90
0.190
 Why?
Macular Degeneration
1
2025
191
0.190
 Why?
Symptom Assessment
1
2024
136
0.190
 Why?
Cicatrix
2
2020
69
0.180
 Why?
Cell Adhesion Molecules, Neuronal
1
2022
42
0.180
 Why?
Adonis
1
2022
1
0.180
 Why?
Nerve Growth Factors
1
2022
79
0.180
 Why?
Medication Adherence
2
2019
540
0.180
 Why?
Brain Infarction
1
2022
23
0.180
 Why?
Esophageal Fistula
1
2022
21
0.180
 Why?
Magnetic Resonance Imaging
4
2020
3915
0.180
 Why?
Diabetes Mellitus
2
2022
1101
0.180
 Why?
Time-to-Treatment
1
2024
251
0.180
 Why?
Ablation Techniques
2
2019
36
0.180
 Why?
Hypertension
3
2023
1276
0.180
 Why?
Remote Sensing Technology
1
2022
17
0.180
 Why?
Patient Preference
1
2024
223
0.180
 Why?
Prosthesis Design
1
2024
356
0.180
 Why?
Obesity
2
2025
3118
0.170
 Why?
Fistula
1
2022
49
0.170
 Why?
Health Equity
1
2024
133
0.170
 Why?
Artificial Intelligence
2
2023
381
0.170
 Why?
Inflammasomes
1
2022
144
0.170
 Why?
Cardiac Catheterization
2
2020
559
0.170
 Why?
Thoracic Injuries
1
2022
71
0.170
 Why?
Perfusion
1
2022
251
0.170
 Why?
Disaccharides
1
2021
21
0.170
 Why?
Lactams
1
2021
28
0.170
 Why?
Cell Death
1
2022
382
0.170
 Why?
Societies, Medical
2
2017
900
0.160
 Why?
Research Report
1
2021
86
0.160
 Why?
Gadolinium
4
2022
84
0.160
 Why?
Receptors, Adrenergic, beta-1
2
2017
24
0.160
 Why?
Transgender Persons
1
2024
210
0.160
 Why?
Adiposity
1
2025
532
0.160
 Why?
Contrast Media
5
2022
497
0.160
 Why?
Esophagus
2
2022
262
0.160
 Why?
Health Services
1
2021
113
0.160
 Why?
Authorship
1
2020
49
0.150
 Why?
Contraindications, Drug
1
2019
10
0.150
 Why?
Kidney
2
2020
1496
0.150
 Why?
Social Class
1
2021
264
0.140
 Why?
HMGB1 Protein
1
2019
51
0.140
 Why?
Monitoring, Physiologic
1
2021
289
0.140
 Why?
Cell Membrane
1
2022
709
0.140
 Why?
Social Determinants of Health
1
2023
309
0.140
 Why?
DNA Demethylation
1
2018
4
0.140
 Why?
Esophageal Diseases
1
2018
30
0.140
 Why?
Telemetry
1
2018
40
0.140
 Why?
Feasibility Studies
2
2020
1115
0.140
 Why?
Natriuretic Peptide, Brain
1
2018
109
0.130
 Why?
Ventricular Dysfunction, Left
1
2021
394
0.130
 Why?
Metoprolol
1
2017
26
0.130
 Why?
Computer Systems
1
2017
55
0.130
 Why?
Sex Factors
2
2021
2110
0.130
 Why?
Drug Substitution
2
2017
63
0.130
 Why?
Evidence-Based Medicine
2
2021
740
0.130
 Why?
North Carolina
2
2014
130
0.130
 Why?
Recurrence
4
2024
1139
0.130
 Why?
Defibrillators
1
2017
23
0.130
 Why?
Reproducibility of Results
4
2020
3416
0.120
 Why?
Venous Thromboembolism
1
2021
328
0.120
 Why?
Choline O-Acetyltransferase
1
2016
26
0.120
 Why?
Nervous System Diseases
1
2020
286
0.120
 Why?
Hemostatic Techniques
1
2017
52
0.120
 Why?
Tertiary Care Centers
1
2017
195
0.120
 Why?
Data Collection
1
2019
643
0.120
 Why?
Hypertrophy, Left Ventricular
2
2015
124
0.120
 Why?
Reflex
1
2016
70
0.120
 Why?
Kaplan-Meier Estimate
2
2018
971
0.120
 Why?
Drug Prescriptions
1
2018
288
0.110
 Why?
Contraindications
1
2015
90
0.110
 Why?
Adrenergic beta-Antagonists
2
2015
252
0.110
 Why?
Hospitals, Community
1
2015
67
0.110
 Why?
Percutaneous Coronary Intervention
1
2020
549
0.100
 Why?
Blood Pressure
2
2023
1782
0.100
 Why?
Renal Insufficiency, Chronic
1
2021
668
0.100
 Why?
Intention to Treat Analysis
1
2014
79
0.100
 Why?
Odds Ratio
2
2013
1083
0.100
 Why?
Surveys and Questionnaires
2
2024
6085
0.100
 Why?
Emergencies
1
2015
174
0.100
 Why?
Cardiology
1
2017
362
0.100
 Why?
Animals
7
2022
38097
0.100
 Why?
Ventilator-Induced Lung Injury
1
2014
61
0.100
 Why?
Premedication
1
2013
45
0.100
 Why?
Double-Blind Method
2
2017
2064
0.100
 Why?
Ischemic Attack, Transient
1
2014
71
0.100
 Why?
Epigenesis, Genetic
1
2018
693
0.100
 Why?
Ticlopidine
1
2013
52
0.100
 Why?
Coronary Disease
2
2006
382
0.100
 Why?
Gene Expression Regulation, Developmental
1
2018
910
0.100
 Why?
Accreditation
1
2013
101
0.090
 Why?
Quality of Health Care
2
2019
693
0.090
 Why?
Thrombosis
1
2017
400
0.090
 Why?
Primary Prevention
1
2014
222
0.090
 Why?
Drug Synergism
1
2013
354
0.090
 Why?
Cerebrovascular Disorders
1
2013
105
0.090
 Why?
Operating Rooms
1
2014
144
0.090
 Why?
Calcium Channel Blockers
1
2013
166
0.090
 Why?
Peripheral Arterial Disease
1
2019
509
0.090
 Why?
Models, Cardiovascular
1
2013
196
0.090
 Why?
Electronics
2
2023
65
0.090
 Why?
Atrioventricular Block
1
2012
44
0.090
 Why?
Critical Illness
1
2018
900
0.090
 Why?
Ventricular Remodeling
1
2014
278
0.090
 Why?
Cross-Sectional Studies
2
2021
5922
0.090
 Why?
Clinical Trials, Phase II as Topic
2
2024
75
0.090
 Why?
Myocardial Ischemia
1
2013
285
0.090
 Why?
Depression
1
2021
1557
0.090
 Why?
Diagnostic Imaging
1
2014
337
0.080
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
261
0.080
 Why?
Continuity of Patient Care
1
2013
297
0.080
 Why?
Risk
1
2013
923
0.080
 Why?
International Normalized Ratio
2
2021
55
0.080
 Why?
Glomerular Filtration Rate
1
2013
765
0.080
 Why?
CD4-Positive T-Lymphocytes
1
2016
1146
0.080
 Why?
Kidney Diseases
1
2013
426
0.070
 Why?
Mice
3
2022
18355
0.070
 Why?
Liver
1
2018
1899
0.070
 Why?
Respiration, Artificial
1
2014
714
0.070
 Why?
Socioeconomic Factors
1
2013
1327
0.070
 Why?
Patient Education as Topic
1
2013
777
0.070
 Why?
Databases, Factual
2
2025
1491
0.060
 Why?
Retreatment
1
2007
80
0.060
 Why?
Referral and Consultation
1
2013
868
0.060
 Why?
Thinness
1
2025
100
0.060
 Why?
Health Knowledge, Attitudes, Practice
1
2013
1420
0.050
 Why?
Signal Transduction
1
2018
5223
0.050
 Why?
Cardiologists
1
2024
45
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2024
133
0.050
 Why?
Drug Therapy, Combination
2
2019
1043
0.050
 Why?
Tomography, X-Ray Computed
1
2014
2770
0.050
 Why?
Gender Identity
1
2024
129
0.050
 Why?
Magnetic Resonance Imaging, Cine
1
2024
214
0.050
 Why?
Syncope
1
2023
56
0.050
 Why?
Echocardiography
1
2025
648
0.050
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
444
0.040
 Why?
Vena Cava, Superior
1
2022
25
0.040
 Why?
Dizziness
1
2023
101
0.040
 Why?
Career Choice
1
2024
235
0.040
 Why?
Mentors
1
2024
217
0.040
 Why?
Flecainide
1
2021
8
0.040
 Why?
Reoperation
1
2024
637
0.040
 Why?
Age of Onset
1
2023
557
0.040
 Why?
Dyspnea
1
2023
250
0.040
 Why?
Peptide Fragments
1
2005
696
0.040
 Why?
Chicago
1
2020
62
0.040
 Why?
Device Removal
1
2022
142
0.040
 Why?
Psychometrics
1
2024
731
0.040
 Why?
Seasons
1
2023
538
0.040
 Why?
Atrial Remodeling
1
2020
10
0.040
 Why?
Current Procedural Terminology
1
2020
19
0.040
 Why?
Meglumine
1
2020
18
0.040
 Why?
Aftercare
1
2022
222
0.040
 Why?
Temperature
1
2023
633
0.040
 Why?
Emergency Service, Hospital
1
2012
2383
0.040
 Why?
Cells, Cultured
2
2018
4151
0.040
 Why?
Intracranial Embolism
1
2019
34
0.040
 Why?
Phenotype
2
2018
3170
0.040
 Why?
Forecasting
1
2021
390
0.040
 Why?
Heart
1
2023
626
0.040
 Why?
Education, Medical, Graduate
1
2024
562
0.040
 Why?
Propensity Score
1
2021
377
0.040
 Why?
International Classification of Diseases
1
2020
150
0.040
 Why?
Myocardial Revascularization
1
2019
85
0.040
 Why?
Peripheral Vascular Diseases
1
2019
104
0.040
 Why?
Hyperlipidemias
1
2019
120
0.040
 Why?
Organometallic Compounds
1
2020
113
0.040
 Why?
Support Vector Machine
1
2018
33
0.040
 Why?
Kidney Failure, Chronic
1
2005
599
0.040
 Why?
Peripheral Nervous System Diseases
1
2019
134
0.030
 Why?
5-Methylcytosine
1
2018
24
0.030
 Why?
Dioxygenases
1
2018
34
0.030
 Why?
Self-Management
1
2021
204
0.030
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2017
18
0.030
 Why?
Patient Safety
1
2021
356
0.030
 Why?
Asymptomatic Diseases
1
2018
104
0.030
 Why?
Consensus
1
2020
479
0.030
 Why?
Diffusion of Innovation
1
2018
96
0.030
 Why?
Primary Cell Culture
1
2018
172
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2017
116
0.030
 Why?
Systole
1
2017
181
0.030
 Why?
Models, Biological
1
2025
1764
0.030
 Why?
Hepatocytes
1
2018
224
0.030
 Why?
Cognitive Dysfunction
1
2023
468
0.030
 Why?
ROC Curve
1
2018
618
0.030
 Why?
Mortality
1
2019
380
0.030
 Why?
Feedback, Physiological
1
2016
80
0.030
 Why?
Mice, Inbred C57BL
2
2018
5992
0.030
 Why?
Longitudinal Studies
1
2023
2967
0.030
 Why?
Sequence Analysis, RNA
1
2018
442
0.030
 Why?
Animals, Newborn
1
2018
896
0.030
 Why?
Proto-Oncogene Proteins
1
2018
625
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2018
534
0.030
 Why?
Patient Satisfaction
1
2019
712
0.030
 Why?
Genetic Testing
1
2017
483
0.030
 Why?
District of Columbia
1
2014
38
0.030
 Why?
Decision Making
1
2022
982
0.030
 Why?
Pandemics
1
2022
1711
0.030
 Why?
Pharmacogenetics
1
2015
175
0.020
 Why?
Abdomen
1
2014
142
0.020
 Why?
Internship and Residency
1
2024
1269
0.020
 Why?
Costs and Cost Analysis
1
2014
221
0.020
 Why?
Genotype
1
2017
1857
0.020
 Why?
Machine Learning
1
2018
587
0.020
 Why?
Polymorphism, Genetic
1
2015
615
0.020
 Why?
Insurance Coverage
1
2014
244
0.020
 Why?
Ambulatory Care
1
2016
610
0.020
 Why?
DNA
1
2017
1437
0.020
 Why?
Mice, Knockout
1
2018
3130
0.020
 Why?
DNA-Binding Proteins
1
2018
1482
0.020
 Why?
Rats
1
2019
5585
0.020
 Why?
Patient Compliance
1
2014
588
0.020
 Why?
Genetic Predisposition to Disease
1
2018
2399
0.020
 Why?
Disease Models, Animal
1
2019
4568
0.020
 Why?
Young Adult
1
2024
14251
0.020
 Why?
Biomarkers
1
2018
4302
0.020
 Why?
Syndrome
1
2006
381
0.010
 Why?
Hirudins
1
2005
53
0.010
 Why?
Adolescent
1
2024
22573
0.010
 Why?
Kidney Function Tests
1
2005
156
0.010
 Why?
Creatinine
1
2005
515
0.010
 Why?
Recombinant Proteins
1
2005
1368
0.010
 Why?
Steinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (410) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)